La Lingua Nostra La Lingua Nostra
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Blogs
  • Offers
  • Jobs
  • Yazı
  • Articles
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • ROHIT GAURYA bir dosya eklendi Health
    2026-04-08 09:52:39 -
    Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
    According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...
    0 Yorumlar 0 hisse senetleri 30 Views 0 önizleme
    Please log in to like, share and comment!
  • ROHIT GAURYA bir dosya eklendi Health
    2026-03-18 09:46:28 -
    Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%
        According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...
    0 Yorumlar 0 hisse senetleri 235 Views 0 önizleme
    Please log in to like, share and comment!
  • Rohit Katkam bir dosya eklendi Other
    2026-04-01 10:05:46 -
    Nucleic Vaccine Market Growth Report 2034: Rising at 2.8% CAGR with Expanding Therapeutic Applications
    According to a new report from Intel Market Research, the global Nucleic Vaccine market was valued at USD 49.34 billion in 2024 and is projected to reach USD 59.64 billion by 2034, growing at a CAGR of 2.8% during the forecast period. This growth reflects the transformative impact of mRNA vaccine technology, particularly evident in the rapid response to the COVID-19 pandemic, alongside...
    0 Yorumlar 0 hisse senetleri 147 Views 0 önizleme
    Please log in to like, share and comment!
© 2026 La Lingua Nostra Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Koşullar Gizlilik Contact Us